Quality Assurance Division
Lab Reports & Certificates
Third-party verified. ISO-accredited. Every batch analyzed by HPLC, mass spectrometry, and endotoxin screening before it reaches you.
Avg Purity
ISO 17025 Accredited
COA Rate
Batches Tested
Analytical Methods
Test Methodology
Every compound undergoes a three-tier analytical pipeline before batch release.
HPLC
High-Performance Liquid Chromatography
Separates, identifies, and quantifies each component in a mixture. Our HPLC analysis confirms peptide purity to 0.01% resolution with UV detection at 214nm wavelength.
MS
Mass Spectrometry
Measures the mass-to-charge ratio of ions to confirm molecular identity. Every batch is verified against the theoretical molecular weight with <0.1 Da deviation.
LAL
Endotoxin (LAL) Testing
Limulus Amebocyte Lysate assay detects bacterial endotoxins to FDA-accepted sensitivity thresholds. Every injectable-grade batch must pass <0.25 EU/mL before release.
Sample Analysis
Certificate of Analysis
Every batch ships with a full COA. Here is what a typical analysis looks like.
Certificate of Analysis
Batch #BPC-26A
Analyzed
2026-01-15
HPLC Chromatogram (214nm)
Recent Batch Purity Results
Document Archive
Latest Analysis Documents
| Product Name | Batch ID | Date | Purity (HPLC) | Document |
|---|---|---|---|---|
| BPC-157 | BPC-26A | Jan 15, 2026 | 99.8% | |
| TB-500 | TB-26A | Jan 18, 2026 | 99.5% | |
| Retatrutide | RET-26B | Feb 01, 2026 | 99.2% | |
| Semaglutide (5mg) | SEM-26A | Jan 10, 2026 | 99.9% | |
| FOXO4-DRI | FOX-26C | Feb 03, 2026 | 98.5% | |
| Ipamorelin / CJC-1295 Blend | IC-26A | Jan 20, 2026 | 99.1% | |
| BPC-157 / TB-500 Blend | BT-26A | Jan 22, 2026 | 99.4% | |
| NAD+ Peptide | NAD-26A | Jan 05, 2026 | 99.7% | |
| GHK-Cu | GHK-26B | Jan 25, 2026 | 99.6% | |
| PT-141 | PT-26A | Jan 12, 2026 | 99.3% |
All compounds are tested by an ISO 17025 accredited third-party laboratory. Reports include HPLC chromatograms, mass spectrometry confirmations, and endotoxin screening results.